Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022

Derek Archila Maintained (CCCC) at Hold with Decreased Target to $9 on, Jan 3rd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -with-decreased-target-to-9-on-jan-3rd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Derek Archila of Wells Fargo, Maintained "C4 Therapeutics, Inc." (CCCC) at Hold with Decreased Target from $11 to $9 on, Jan 3rd, 2023.

Derek has made no other calls on CCCC in the last 4 months.



There are 2 other peers that have a rating on CCCC. Out of the 2 peers that are also analyzing CCCC, 1 agrees with Derek's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Joseph of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $15 on, Friday, November 4th, 2022


This is the rating of the analyst that currently disagrees with Derek


  • Terence Flynn of "Morgan Stanley" Initiated at Sell and Held Target at $6 on, Tuesday, October 11th, 2022

Publication Contributing Sources